Pharmacotherapy for primary biliary cholangitis: an assessment of medication candidacy and rates of treatment.

"Declarations Ethics approval and consent to participateOur study was reviewed by the Thomas Jefferson University Office of Human Research’s institutional review board (IRB), and our study protocol was determined to be IRB exempt. The need for written informed consent was waived by the Thomas Jefferson University Office of Human Research’s institutional review board (IRB). Consent for publicationOur study was reviewed by the Thomas Jefferson University Office of Human Research’s institutional review board (IRB), and our study protocol was determined to be IRB exempt. This manuscript does not contain any individual person’s data. All data are reported in aggregate form and consent for publication was therefore not applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding No funding was required to complete this study."